Cardiovascular diseases account for approximately 30% of deaths worldwide and remain a leading cause of morbidity and ...
BACKGROUND: Classically, hypertrophic cardiomyopathy (HCM) has been viewed as a single-gene (monogenic) disease caused by ...
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a major health concern. Pathological stimuli and interactions between cardiac fibroblasts (CFs) and other cell types may lead to ...
Cardiovascular Division and Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville. For Sources of Funding and Disclosures, see page ...
Background: In severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM), VALOR-HCM trial (Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are ...
View all available purchase options and get full access to this article.
View all available purchase options and get full access to this article.
View all available purchase options and get full access to this article. Wagner R, Heni M, Tabak AG, Machann J, Schick F, Randrianarisoa E, Hrabe de Angelis M, Birkenfeld AL, Stefan N, Peter A, et al.
Adults who maintain ideal cardiovascular health (CVH) profiles up to midlife have lower risk of several chronic diseases and better quality of life. Some evidence suggests that individual‐level ...
View all available purchase options and get full access to this article.
Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials
View all available purchase options and get full access to this article.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback